WINNINGHAM RICK E (Chief Executive Officer) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/22/2023ACC: 0001415889-23-012522
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-15.80K
Net shares
Net seller
$153.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
15.80K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−15.80K
Price / share
$9.70
Trade value
$153.30K
% of position
1.0%
8/20/2023
1.63M→1.61M
Total
Net shares
−15.80K
Net value
-$153.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2023 | F · Tax Withholding | −15.80K | $9.70 | $153.30K | 1.0% | 1.63M | 1.61M |
| Total | −15.80K | -$153.30K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Ordinary Shares
IndirectShares owned92.57K
Total
92.57K indirect92.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 92.57K | Indirect |
| Total | 92.57K | 92.57K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported